Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid Corp. stock sank 5.7% in Friday trading after the stock was downgraded to underweight from neutral at JPMorgan. Analysts slashed their price target to $12 from $21.

Rite Aid stock slumps 18% for the week as weak outlook, diminished vaccine tailwind drive JPMorgan downgrade

Rite Aid's (RAD) Q1 results gain from accelerated vaccinations, the RxEvolution strategy and robust online growth.

Rite Aid's (RAD) Q1 Earnings Beat Estimates, Sales Miss

KB Home

As stock markets head for records, looking for disconnects between fundamentals and stock movements can be lucrative.

Strong Earnings, Falling Share Prices Make These 2 Stocks More Attractive

The company's latest guidance left much to be desired, to put it mildly.

Why Rite Aid Is Sinking This Week

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q1 2022 Results - Earnings Call Transcript

Rite Aid Corp (NYSE:RAD) shares plunged 13% Thursday morning after the company's most recent quarterly report. RAD reported earnings the beat expectations on Thursday morning, but revenues came short of estimates.

Should you buy Rite Aid after the earnings beat?

Shares of Rite Aid sank roughly 14% on Thursday, as Wall Street digested mixed quarterly results and weaker earnings guidance.

Rite Aid shares plummet; CEO cites Covid uncertainty for drug store chain's cautious outlook

Rite Aid Corp. (NYSE: RAD) said on Thursday its revenue in the fiscal first quarter came in weaker than expected, attributed to the pharmacy services business. Its Q1 profit, however, topped Wall Street estimates.

Rite Aid CEO plays defence on CNBC as stock falls 12%

Rite Aid, which has more than 2,500 retail pharmacy locations throughout 17 states, reported that revenues from continuing operations climbed by 2.2 percent to $6.16 billion. For the three months ending May 29, 2021, the retailer said that the rise in revenues was fueled by growth in its retail pharmacy segment that was offset, in part, […]

Rite Aid's Retail Pharmacy Business Drives Revenue Growth

The shares of Rite Aid Corporation (NYSE:RAD) are sitting out the broad market rally  today, last seen down 14.3% to trade at $17.48 after the pharmacy giant reported lackluster fiscal first-quarter results.

Options Traders Respond to Rite Aid's Revenue Miss

Rite Aid administered 4.7 million vaccines against Covid-19 in the company's first quarter, boosting sales.

Covid-19 Vaccines Boost Rite Aid Sales

Shares of Rite Aid (NYSE:RAD) moved higher by 2.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 1050.00% over the past year to $0.38, which beat the estimate of $0.22.

Recap: Rite Aid Q1 Earnings

Shares of Rite Aid Corp. sank 5.5% in premarket trading Thursday, after the drugstore chain beat fiscal first-quarter profit expectations but came up shy on revenue, amid weakness in the pharmacy services business, while also providing a mixed full-year outlook. The net loss for the quarter to May 29 narrowed to $13.1 million, or 24 cents a share, from $63.5 million, or $1.19 a share, in the year-ago period.

Rite Aid's stock sinks after profit beats, but revenue comes up shy

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today published its third annual corporate sustainability report, detailing the company's enhanced Environmental, Social and Governance (ESG) strategy. The report introduces four key pillars underpinning Rite Aid's sustainability efforts: building a thriving planet, thriving business, thriving workplace and thriving community. “As a healthcare organization that aspires to support the whole health of its communities, we understand the critica

Rite Aid Releases Third Annual Corporate Sustainability Report

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its first fiscal quarter ended May 29, 2021. For the first quarter, the company reported net loss from continuing operations of $13.1 million, or $0.24 loss per share, Adjusted net income from continuing operations of $20.9 million, or $0.38 income per share, and Adjusted EBITDA from continuing operations of $138.9 million, or 2.3 percent of revenues. “We are pleased with our first quarter res

Rite Aid Corporation Reports Fiscal 2022 First Quarter Results

Rite Aid stock fell sharply after last quarter's results. Heavy debt an ongoing concern.Investor interest in bricks-and-mortar retail drug stores may rise.

Buy Rite Aid And Bet On Revenues Rebounding

Strength in PBM and Elixir and expanded omnichannel services are likely to have aided Rite Aid (RAD) in Q1. However, rising pandemic costs and low testing demand are likely to have been worrisome.

Factors Likely to Influence Rite Aid's (RAD) Q1 Earnings

Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rite Aid (RAD) Reports Next Week: Wall Street Expects Earnings Growth

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced that Andre Persaud has been named chief retail officer. Persaud was appointed executive vice president, retail for Rite Aid in February 2020 and assumed responsibility for orchestrating new in-store experiences and retail operations processes in line with the company's RxEvolution strategy. “Andre has not only proven an effective leader for our retail organization, but also provides a strategic and steady leadership voice in

Rite Aid Promotes Andre Persaud to Chief Retail Officer

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2022 First Quarter, which ended May 29, 2021, on Thursday, June 24, 2021. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. Eastern Time on Thursday, June 24, 2021 and e

Rite Aid to Release First Quarter Results on June 24

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is proud to support the White House and the National Month of Action by extending vaccination hours at select locations in June to make it easier to get vaccinated against COVID-19 and advance equity. This initiative to improve vaccine access and equity, is in accordance with the federal government's nationwide effort to get 70% of U.S. adults at least one shot by July 4, 2021. Rite Aid will launch ‘Night Shots' Friday, June 11, and extend v

Rite Aid Extends Vaccinating Hours Every Friday in June to Increase COVID-19 Vaccine Accessibility

Drugstore chain Rite Aid Corporation (NYSE:RAD) is the largest chain on the East Coast and the third largest in the U.S. The stock is up 32.2% in 2021, with its 320-day moving average serving as a stable floor since April.

Rite Aid Stock Keeps Churning in a Tight Channel

CVS Health

Walgreens

CVS (NYSE: CVS), Walgreens (NASDAQ: WBA) and Rite Aid (NYSE: RAD) shares lost ground Wednesday after a Business Insider report that Amazon (NASDAQ: AMZN) is considering entering the physical pharmacy retail space. The story's three unnamed sources, who were not authorized to speak to the press, said there is no concrete plan, but rather exploratory discussions are taking place.

CVS, Walgreens, Rite Aid Shares Fall On Report Of Potential Amazon Entry Into Retail Pharmacy

AmerisourceBergen

Cardinal Health

McKesson

Shares of drug retailers including Walgreens Boots Alliance  and CVS dropped on Wednesday, as Amazon was reported to be looking at options to set up physical pharmacy locations in the US.  Talks at Amazon about setting up standalone pharmacies are mostly exploratory and there are no firm plans to open physical locations, three people familiar with the matter told Insider.  Such a move would be part of a plan by the online retail behemoth to earn a larger share of the country's $370 billion prescription drug market.

Pharmacy stocks tumble on report Amazon is weighing a push into physical pharmacies (AMZN, CVS, RAD, WAG, CAH, MCK, ABC)

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it is administering COVID-19 vaccines to anyone 12 or older at all locations offering the Pfizer vaccine, following the latest guidance from the Centers for Disease Control and Prevention (CDC). Guardians for individuals under 18 can now schedule appointments using the Rite Aid scheduling tool found at www.RiteAid.com/covid-19. Those ages 12 through 17 are only authorized to be vaccinated with the Pfizer vaccine, per CDC guid

News for Rite Aid Stock (RAD)